Allspring Global Investments Holdings LLC Reduces Holdings in Synopsys, Inc. $SNPS

Key Points

• Allspring Global Investments Holdings LLC reduced its stake in Synopsys, Inc. by 3.0%, owning 52,348 shares valued at approximately $27.3 million after selling 1,628 shares during Q2.
• Various hedge funds, including Vanguard Group Inc. and Pictet Asset Management, have increased their holdings in Synopsys during the first quarter, indicating a trend among institutional investors.
• Synopsys recently reported earnings of $2.30 per share, falling short of estimates by $1.45, and provided a FY 2025 guidance of $12.760-12.800 EPS.

Allspring Global Investments Holdings LLC trimmed its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 3.0% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 52,348 shares of the semiconductor company's stock after selling 1,628 shares during the period. Allspring Global Investments Holdings LLC's holdings in Synopsys were worth $27,314,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the business. Vanguard Group Inc. grew its stake in Synopsys by 2.4% in the 1st quarter. Vanguard Group Inc. now owns 14,829,770 shares of the semiconductor company's stock worth $6,359,747,000 after acquiring an additional 346,994 shares during the period. Pictet Asset Management Holding SA grew its stake in Synopsys by 38.3% in the 1st quarter. Pictet Asset Management Holding SA now owns 2,432,596 shares of the semiconductor company's stock worth $1,043,518,000 after acquiring an additional 673,837 shares during the period. Ameriprise Financial Inc. grew its stake in Synopsys by 6.6% in the 1st quarter. Ameriprise Financial Inc. now owns 2,013,380 shares of the semiconductor company's stock worth $863,500,000 after acquiring an additional 125,199 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in Synopsys by 20.2% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,816,319 shares of the semiconductor company's stock worth $778,928,000 after acquiring an additional 305,489 shares during the period. Finally, Alliancebernstein L.P. grew its stake in Synopsys by 22.2% in the 1st quarter. Alliancebernstein L.P. now owns 1,725,211 shares of the semiconductor company's stock worth $739,857,000 after acquiring an additional 313,218 shares during the period. 85.47% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Synopsys

In other Synopsys news, Director Robert G. Painter bought 350 shares of Synopsys stock in a transaction that occurred on Thursday, September 11th. The shares were acquired at an average price of $425.44 per share, for a total transaction of $148,904.00. Following the acquisition, the director owned 2,291 shares of the company's stock, valued at $974,683.04. The trade was a 18.03% increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Also, CAO Sudhindra Kankanwadi sold 9,873 shares of Synopsys stock in a transaction on Monday, September 22nd. The shares were sold at an average price of $500.90, for a total transaction of $4,945,385.70. Following the transaction, the chief accounting officer owned 20,520 shares in the company, valued at $10,278,468. The trade was a 32.48% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 30,894 shares of company stock worth $16,760,783. Insiders own 0.62% of the company's stock.

Synopsys Stock Performance

NASDAQ:SNPS opened at $440.20 on Friday. The company has a current ratio of 1.62, a quick ratio of 1.51 and a debt-to-equity ratio of 0.52. The firm has a market capitalization of $81.77 billion, a price-to-earnings ratio of 34.55, a PEG ratio of 4.80 and a beta of 1.10. The firm's fifty day simple moving average is $529.15 and its 200 day simple moving average is $510.15. Synopsys, Inc. has a twelve month low of $365.74 and a twelve month high of $651.73.

Synopsys (NASDAQ:SNPS - Get Free Report) last posted its earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 earnings per share for the quarter, missing the consensus estimate of $3.75 by ($1.45). The business had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.77 billion. Synopsys had a net margin of 31.04% and a return on equity of 10.82%. The business's revenue was up 14.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $3.43 EPS. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. As a group, equities research analysts expect that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

SNPS has been the subject of several recent analyst reports. Stifel Nicolaus lowered their target price on shares of Synopsys from $650.00 to $550.00 and set a "buy" rating for the company in a research note on Wednesday, September 10th. Baird R W lowered shares of Synopsys from a "strong-buy" rating to a "hold" rating in a report on Wednesday, September 10th. Weiss Ratings reiterated a "hold (c)" rating on shares of Synopsys in a report on Wednesday, October 8th. Wells Fargo & Company decreased their price target on shares of Synopsys from $630.00 to $550.00 and set an "equal weight" rating on the stock in a report on Wednesday, September 10th. Finally, Zacks Research lowered shares of Synopsys from a "hold" rating to a "strong sell" rating in a report on Friday, September 12th. Ten analysts have rated the stock with a Buy rating, five have issued a Hold rating and four have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $569.67.

Synopsys Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.